Mon, March 11, 2019
Fri, March 8, 2019
Thu, March 7, 2019
Wed, March 6, 2019
Tue, March 5, 2019
Mon, March 4, 2019

David Risinger Downgraded (TEVA) to Hold and Held Target at $17 on, Mar 6th, 2019

David Risinger of Morgan Stanley, Downgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Hold and Held Target at $17 on, Mar 6th, 2019.

David has made no other calls on TEVA in the last 4 months.



There are 4 other peers that have a rating on TEVA. Out of the 4 peers that are also analyzing TEVA, 2 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Vamil Divan of "Credit Suisse" Maintained at Hold with Decreased Target to $20 on, Thursday, February 14th, 2019
  • David Amsellem of "Piper Sandler" Upgraded from Sell to Hold and Increased Target to $16 on, Wednesday, January 23rd, 2019


These are the ratings of the 2 analyists that currently disagree with David


  • Elliot Wilbur of "Raymond James" Upgraded from Hold to Buy on, Thursday, February 14th, 2019
  • Jason Gerberry of "B of A Securities" Upgraded from Sell to Strong Buy on, Thursday, January 3rd, 2019